FDA Sues NJ Compounder Over Mold-Contaminated Products

Law360, New York (June 25, 2013, 7:14 PM ET) -- The U.S. Food and Drug Administration on Friday slapped drug compounding facility Med Prep Consulting Inc. and its senior executive with a lawsuit in New Jersey federal court for circulating intravenous medicines infected with mold and for failing to secure proper approval for some of its medications.

The government is seeking a permanent injunction to cease all of Med Prep's operations until its distribution methods are improved. The allegations stem from a Med Prep recall in March following the discovery of mold in several of its...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

UNITED STATES OF AMERICA v. MED PREP CONSULTING, INC et al


Case Number

3:13-cv-03856

Court

New Jersey

Nature of Suit

Other Statutory Actions

Judge

Peter G. Sheridan

Date Filed

June 21, 2013

Law Firms

Companies

Government Agencies